Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Northrim BanCorp Inc is a banks-regional business based in the US. Northrim BanCorp shares (NRIM) are listed on the NASDAQ and all prices are listed in US Dollars. Northrim BanCorp employs 451 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $41.71 |
|---|---|
| 52-week range | $37.36 - $46.04 |
| 50-day moving average | $40.85 |
| 200-day moving average | $43.02 |
| Wall St. target price | $50.00 |
| PE ratio | 7.8137 |
| Dividend yield | $1.58 (4.11%) |
| Earnings per share (TTM) | $5.26 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $41.71 from 2022-06-28
| 1 week (2022-06-22) | 3.94% |
|---|---|
| 1 month (2022-05-27) | -0.26% |
| 3 months (2022-03-30) | -4.86% |
| 6 months (2021-12-30) | -4.77% |
| 1 year (2021-06-30) | -2.43% |
|---|---|
| 2 years (2020-06-30) | 65.91% |
| 3 years (2019-06-28) | 16.97% |
| 5 years (2017-06-29) | 36.75% |
Valuing Northrim BanCorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Northrim BanCorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Northrim BanCorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Northrim BanCorp shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $128.6 million |
|---|---|
| Operating margin TTM | 31.95% |
| Gross profit TTM | $137.2 million |
| Return on assets TTM | 1.31% |
| Return on equity TTM | 14.24% |
| Profit margin | 25.32% |
| Book value | $38.40 |
| Market capitalisation | $239.1 million |
TTM: trailing 12 months
Dividend payout ratio: 30.04% of net profits
Recently Northrim BanCorp has paid out, on average, around 30.04% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Northrim BanCorp shareholders could enjoy a 4.11% return on their shares, in the form of dividend payments. In Northrim BanCorp's case, that would currently equate to about $1.58 per share.
While Northrim BanCorp's payout ratio might seem fairly standard, it's worth remembering that Northrim BanCorp may be investing much of the rest of its net profits in future growth.
Northrim BanCorp's most recent dividend payout was on 16 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 7 June 2022 (the "ex-dividend date").
Northrim BanCorp's shares were split on a 105:100 basis on 18 September 2007. So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your Northrim BanCorp shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for Northrim BanCorp shares which in turn could have impacted Northrim BanCorp's share price.
Over the last 12 months, Northrim BanCorp's shares have ranged in value from as little as $37.361 up to $46.0411. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Northrim BanCorp's is 0.7128. This would suggest that Northrim BanCorp's shares are less volatile than average (for this exchange).
Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement and money market deposit accounts, certificates of deposit, and business sweep accounts. It also provides short and medium-term commercial loans, commercial credit lines, construction and real estate loans, and consumer loans, as well as short-term working capital. In addition, the company offers other services comprising consumer and business online banking, mobile app, and mobile deposits; and debit and credit cards. Further, it provides mobile web and text banking, consumer online account opening, personal finance, online documents, consumer debit cards, business debit cards, my rewards for consumer debit cards, retail lockbox, card control, business employee purchase cards, home equity advantage access cards, telebanking, and automated teller services.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.